Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder

Journal of Psychiatric Research

Volumn 41, Issue 3-4, 2007, Pages 332-337

  Husted, David S ^a   Shapira, Nathan A ^a   Murphy, Tanya K ^a   Mann, Giselle D ^a   Ward, Herbert E ^a   Goodman, Wayne K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Obsessive compulsive disorder; Tics; Tourette's syndrome

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; OPEN STUDY; PRIORITY JOURNAL; THERAPY EFFECT; TIC; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TICS;

EID: 33845202586     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.05.007     Document Type: Article

References (37)

1. Anderson G.M., Leckman J.F., and Cohen D.J. Neurochemical and neuropeptide systems. In: Leckman J.F., and Cohen D.J. (Eds). Tourette's Syndrome tics, obsessions, compulsions - developmental psychopathology and clinical care (1998), Wiley, New York 261-281
2. Bebbington P.E. Epidemiology of obsessive-compulsive disorder. Br J Psychiatry 35 Supplement (1998) 2-6
3. Berardelli A., Curra A., Fabbrini G., Gilio F., and Manfredi M. Pathophysiology of tics and Tourette syndrome. J Neurol 250 (2003) 781-787
4. Casey D.E., Haupt D.W., Newcomer J.W., Henderson D.C., Sernyak M.J., Davidson M., et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 65 Suppl. 7 (2004) 4-18
5. Coffey B.J., Miguel E.C., Biederman J., Baer L., Rauch S.L., O'Sullivan R.L., et al. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different?. J Nervous Mental Dis 186 4 (1998) 201-206
6. Eapen V., Pauls D.L., and Robertson M.M. Evidence for autosomal dominant transmission in Tourette's syndrome - United Kingdom Cohort study. Br J Psychiatry 162 (1993) 593-596
7. Ernst M., Zametkin A.J., Jons P.H., Matochik J.A., Pascualvaca D., and Cohen R.M. High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolescent Psychiatry 38 (1999) 86-94
8. Gadow K.D., Nolan E.E., Sprafkin J., and Schwartz J. Tics and psychiatry comorbidity in children and adolescents. Dev Med Child Neurol 44 (2002) 330-338
9. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown obsessive compulsive scale. I: development, use, and reliability. Arch Gen Psychiatry 46 (1989) 1006-1011
10. Goodman W.K., Ward H.E., Kablinger A.S., and Murphy T.K. Biological approaches to treatment-resistant obsessive-compulsive disorder. In: Goodman W.K., Rudorfer M.V., and Maser J.D. (Eds). Obsessive-compulsive disorder: contemporary issues in management (2000), Lawrence Erlbaum Associates, London, UK 333-369
11. Guy W. Early Clinical Drug Evaluation Unit (ECDEU) assessment manual for psychopharmacology, revised. NIMH Publication No. ADM 76-338. Bethesda, MD: National Institute of Mental Health, 1976. p. 217-22.
12. Hoekstra P.J., Anderson G.M., Limburg P.C., Korf J., Kallenberg C.G., and Minderaa R.B. Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 61 (2004) 886-898
13. Husted D.S., and Shapira N.A. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation. CNS Spectrums 9 11 (2004) 833-847
14. Husted D.S., Shapira N.A., and Goodman W.K. Obsessive-compulsive disorder. In: Tarazi F.I., and Schetz J.A. (Eds). Manual of neuropsychiatric disorders (2004), Humana Press, Towota, NJ 171-188
15. Kaufman A.S., and Kaufman N.L. Kaufman brief intelligence test (KBIT) (1990), American Guidance Service, Circle Pines, MN
16. Kurlan R., Como P.G., and Miller B. The behavioral spectrum of tic disorders. A community-based study. Neurology 59 (2002) 414-420
17. Leckman J.F. Phenomenology of tics and natural history of tic disorders. Brain Dev 25 Suppl. 1 (2003) S24-S28
18. Leckman J.F., and Riddle M.A. Tourette's syndrome: when habit-forming systems form habits of their own?. Neuron 28 (2000) 349-354
19. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolescent Psychiatry 28 (1989) 566-573
20. Leonard H.L., Lenane M.C., Swedo S.E., Rettew D.C., Gershon E.S., and Rapoport J.L. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 149 (1992) 1244-1251
21. Lougee L., Perlmutter S.J., Nicolson R., Garvey M.A., and Swedo S.E. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolescent Psychiatry 39 (2000) 1120-1126
22. Marek G.J., Carpenter L.L., McDougle C.J., and Price L.H. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28 (2003) 402-412
23. McDougle C.J., Goodman W.K., Leckman J.F., Barr L.C., Heninger G.R., and Price L.H. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 13 (1993) 354-358
24. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., and Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 51 4 (1994) 302-308
25. Miguel E.C., Shavitt R.G., Ferrao Y.A., Brotto S.A., and Diniz J.B. How to treat OCD in patients with Tourette syndrome. J Psychosomatic Res 55 (2003) 49-57
26. Newcomer J.W. Metabolic risk during antipsychotic treatment. Clin Therapeut 26 12 (2004) 1936-1946
27. Pauls D.L. The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome. Psychiat Clin North Am 15 (1992) 759-766 (Review)
28. Pauls D.L., and Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behavior-evidence for autosomal dominant transmission. New England J Med 315 (1986) 993-997
29. Pauls D.L., Towbin K.E., Leckman J.F., Zahner G.E., and Cohen D.J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry 43 (1986) 1180-1182
30. Pauls D.L., Alsobrook II J.P., Goodman W.K., Rasmussen S., and Leckman J.F. A family study of obsessive-compulsive disorder. Am J Psychiatry 152 1 (1995) 76-84
31. Scahill L., Riddle M.A., King R.A., Hardin M.T., Rasmusson A., Makuch R.W., et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolescent Psychopharmacol 7 2 (1997) 75-85
32. Shapira N.A., Ward H.E., Mandoki M., Murphy T.K., Yang M.C.K., Blier P., et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry 550 (2004) 553-555
33. Singer H.S. Tourette's syndrome: from behaviour to biology. Lancet Neurol 4 3 (2005) 149-159
34. Singer H., and Minzer K. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 25 Suppl. 1 (2003) S70-S84
35. Snider L.A., Seligman L.D., and Ketchen B.R. Tics and problem behaviors in schoolchildren: prevalence, characterization and associations. Pediatrics 110 (2002) 331-336
36. Spencer T., Biederman J., Coffey B., Geller D., Crawford M., Bearman S.K., et al. A double blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid ADHD. Arch Gen Psychiatry 59 7 (2002) 649-656
37. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155 2 (1998) 264-271